Safety Study of Three Formulations of the Dermal Implant ELAPR

NCT01467778 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Conditions

Interventions

DEVICE: ELAPR
DEVICE: ELAPR

Sponsor

Elastagen Pty Ltd